Memooma treatment: considerations and options other than surgery
The emergence of cervioma, the most common benign tumour in the female genitals, often leaves the patient confused about the treatment, especially if only surgically available. In fact, surgery was not the only way, and treatment programmes should be judged by a combination of factors.
For most uterus patients, a strategy of regular observation can be adopted if myomas are small and do not give rise to obvious symptoms, such as excessive menstruation, menstruation, urination frequency, urination, abdominal pain, constipation, etc., or affect reproductive function. The changes in the size, number and location of myoomas are closely monitored through regular gynaecology ultrasounds, usually every 3 – 6 months. Because part of the uterus musculoma may grow very slowly, even after the menopause, it shrinks as estrogen levels decline. For example, the gradual reduction of estrogens in women near menopausal periods and the loss of major irritation factors for uterus tumours may not continue to grow, but rather become smaller, and it is clear that excessive and active surgical intervention is unnecessary in this context.
Drug treatment is also an important non-surgery tool. It may be taken into account when the patient is suffering from mild symptoms, near menopausal age or when the whole body is unfit for surgery. The most common drug is the adenogen release hormone analogue, which can reduce estrogen levels by inhibiting the argon-promotive hormonal secretion and reducing musculoma. However, such drugs are generally not available for long periods of time, as long-term low estrogen conditions can give rise to hysteria syndromes such as heat, sweat theft, osteoporosis, and urology symptoms such as vaginal drying and sexual depreciation. It can also be used as a disincentive to myooma by competing for sterogen receptors, but there are also side effects, such as the potential for uterine membrane growth, so it needs to be used under strict medical guidance.
Cervical embolism is an interventional treatment. It relieves the symptoms by blocking the blood artery of the uterine tumour, which causes the death and contraction of the aminomas as a result of ischaemic oxins. This approach applies to patients with symptoms of uterus tumours, in particular those who wish to retain the uterus, who have poor or unwilling surgery. However, this method may cause post-embolism syndromes such as abdominal pain, fever, nausea, vomiting, etc., and the effects on the reproductive function are not yet clear, so that women with reproductive needs need to be carefully selected.
High-intensity focus ultrasound treatment uses the focus of ultrasound to concentrate energy in the area of myooma, which increases the temperature of myooma and results in condensation and death, and is gradually absorbed or plastered in the organism. It has advantages such as no surgery, no bloodshed and little pain, and is an optional treatment for patients with small and symptoms of myooma. It may, however, have problems of incomplete treatment, re-emergence of myooma, and may not have the desired effect on larger myoomas.
The age of the patient, the fertility requirements, the severity of the symptoms, the size, number and location of myooma are important factors to be taken into account in determining the treatment. In the case of young women with reproductive requirements, if myooma is small and does not affect uterus morphology, there may be a first attempt at medical or other non-surgery treatment, which can be dealt with further after childbirth, depending on the circumstances. In the case of older patients with severe symptoms, aminomas or malignancies, there may be a need for surgical treatment, including in the form of myomactomy (retention of uterus) and hysterectomy, depending on the specific circumstances of the patient.
It is not the only option for uterine tumours, and the patient should communicate fully with the doctor, taking into account all aspects of his/her situation and weighing the advantages and disadvantages of different treatments, so that he/she can choose the individualized treatments that are best suited to his/her condition, while preserving the function of reproduction, reducing complications and improving the quality of life while effectively treating the disease.
A uterus tumor.
